Bill · H.Res. 903· House(119-HRES-903)
Expressing support for the designation of November as "Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome Awareness Month".
- Introduced
- 11/20/2025
- Last activity
- 11/20/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Paul Tonko
- Cosponsors
- - 0 - 1
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
This resolution expresses support for designating November as "Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome Awareness Month." The text notes that Complex Regional Pain Syndrome is a rare, neuro-inflammatory syndrome that can lead to disability and has no known cure. It highlights that patients often face challenges obtaining a diagnosis and accessing specialized medical care. The resolution emphasizes the need for research and development to advance treatments. Finally, it recognizes the importance of improving awareness and advancing research through the designated month.
Yes· 3 of 8
Would people in middle age be better off under this?+3
The resolution notes that peak incidence of the condition occurs in middle-aged adults.
Would people over 65 be better off under this?+3
The resolution notes that peak incidence of the condition occurs in older adults.
Would women be better off under this?+3
The resolution identifies that the condition is significantly more common in women than men.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Awareness and Information: The designation of a specific awareness month is expected to provide hope and information for patients, caregivers, and families across the country (Resolution, Section 2).
-
Improved Medical Outcomes: The resolution recognizes the importance of improving awareness to encourage accurate and early diagnosis, which is critical as the condition can become debilitating without early diagnosis and appropriate treatment (Resolution, Section 2; Whereas clauses).
-
Advancement of Treatments: The resolution highlights the importance of advancing research and developing new treatments, diagnostics, and cures for the condition (Resolution, Section 2).
-
Regulatory Progress: The designation recognizes the importance of identifying regulatory pathways for drug development for ultrarare diseases like Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome (Resolution, Section 2).
Potential Negative Impacts for People
- No negative impacts or burdens are explicitly mentioned in the text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Middle Aged+3Good For People With Disabilities+3Good For Seniors+3Good For Women+3Good For Children+1
- Healthcare
- Improves Healthcare Access+3Increases Research Funding+2
- Social Issues And Justice
- Improves Disability Rights+2
- 11/20/2025
- Submitted in House
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
Mariannette Miller-MeeksRepublican · Iowa